Breaking News
Start for Free 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks
Close

Bayer AG (BAYGn)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.16 -0.96    -4.55%
13/11 - Closed. Currency in EUR
  • Volume: 2,671
  • Bid/Ask: 20.11 / 20.20
  • Day's Range: 20.09 - 21.14
Type:  Equity
Market:  Germany
ISIN:  DE000BAY0017 
S/N:  BAY001
Bayer 20.16 -0.96 -4.55%

Bayer Company Profile

 
Read the Bayer company profile to learn more about the business and the management team. View Bayer AG NA facts about how many employees Bayer has, BAYGn company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

96567

Equity Type

ORD

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Contact Information

Address Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone 49 214 30 1
Fax -

Top Executives

Name Age Since Title
Norbert Winkeljohann 64 2018 Independent Chairman of Supervisory Board
Daniel Hartert 63 - Chairman of Executive Board - Bayer Business Services
Ertharin Cousin 65 2019 Independent Member of the Supervisory Board
Horst Baier 66 2020 Independent Member of Supervisory Board
Gunter Hilken 68 - Chairman of Executive Board - Currenta
Heike Hausfeld 59 2017 Vice Chairwoman of Supervisory Board
Paul M. L. Achleitner 68 2002 Member of Supervisory Board
Heinz Georg Webers 65 2022 Employee Representative Member of Supervisory Board
Colleen A. Goggins 70 2017 Independent Member of Supervisory Board
Norbert W. Bischofberger 68 2017 Independent Member of Supervisory Board
Alberto Weisser 69 2021 Independent Supervisory Board Member
Otmar D. Wiestler 68 2014 Independent Member of Supervisory Board
Frank Löllgen 63 2015 Member of Supervisory Board
Francesco Grioli 52 2022 Employee Representative Member of the Supervisory Board
Claudia Schade 46 2022 Employee Representative Supervisory Board Member
Yasmin Fahimi 57 2022 Employee Representative Member of Supervisory Board
André van Broich 54 2012 Member of Supervisory Board
Lori A. Schechter 62 2024 Independent Supervisory Board Member
Barbara Gansewendt 61 2022 Employee Representative Supervisory Board Member
Jeffrey Williams Ubben 63 2024 Member of the Supervisory Board
Simone Bagel-Trah 55 2014 Independent Member of Supervisory Board
Michael Westmeier 52 2022 Employee Representative Member of the Supervisory Board
Kimberly Mathisen 52 2022 Independent Member of the Supervisory Board
Nancy A. Simonian 63 2024 Independent Member of Supervisory Board
Andrea Sacher 43 2020 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Bayer (BAYGn) Price Discussion

Write your thoughts about Bayer AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Henry James
Henry James 9 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bankrupt!!!
Kostantinos Oikonomou
Kostantinos Oikonomou Feb 08, 2024 9:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sellllll it’s junk
Million Dollar
Million Dollar Nov 27, 2023 16:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
40 from here. 31.56 buy time. Hold till 43
ifigeneia ifigeneia
ifigeneia ifigeneia Jan 13, 2023 22:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next week below 40 euros to 35 euros
ifigeneia ifigeneia
ifigeneia ifigeneia Jan 13, 2023 22:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next week 40 euros soonest!
ifigeneia ifigeneia
ifigeneia ifigeneia Jan 13, 2023 22:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next week 47 euros
Xxx
Xxx Jan 07, 2023 13:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 70
ifigeneia ifigeneia
ifigeneia ifigeneia Aug 04, 2021 17:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tomorrow below @45 euros
ifigeneia ifigeneia
ifigeneia ifigeneia Jul 30, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bayer's bankruptcy comes soon before earning calls
Alex wan
Alex wan May 27, 2021 8:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
These roundup cases will never end isnt it! Seriously took them 3 years and still ongoing!
Robin Mitha
Robin Mitha May 27, 2021 8:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
True, see how long the Bhopal tragedy haunted Dow.... and this is much bigger as Roundup has been used all over the world for decades
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email